DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
QUININE BISULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
QUININE BISULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
M201HC068W
Molecule Type:
Small molecule
Molecular Formula:
C20H28N2O10S2
Molecular Weight:
520.58
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
4
Combination
Approved
IMMUNE SYSTEM; OTHER
TOPICAL
Unknown
Unknown
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTITHROMBIN ALFA
4
Protein
Approved
Unknown
Unknown
Disseminated Intravascular Coagulation; Pre-Eclampsia; Antithrombin III Deficiency
Coagulation factor X inhibitor
ANTITHROMBIN ALFA
×
Maximum Phase:
4
First Approval:
None
UNII:
AWV6I5L6H2
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VINYL CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
VINYL CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
WD06X94M2D
Molecule Type:
Small molecule
Molecular Formula:
C2H3Cl
Molecular Weight:
62.5
AlogP:
1.37
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CLOPIDOGREL ACTIVE METABOLITE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CLOPIDOGREL ACTIVE METABOLITE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENIDIPINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Voltage-gated L-type calcium channel blocker
BENIDIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
4G9T91JS7E
Molecule Type:
Small molecule
Molecular Formula:
C28H31N3O6
Molecular Weight:
505.57
AlogP:
4.21
PSA:
111.01
HBD:
1.0
HBA:
#RotB:
7.0
Source:
brolucizumab-dbll
4
Unknown
Approved
Unknown
INTRAVITREAL
Unknown
Unknown
brolucizumab-dbll
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVALGLUCOSIDASE ALFA-NGPT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
AVALGLUCOSIDASE ALFA-NGPT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M GLUCEPTATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M GLUCEPTATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HALOBETASOL PROPIONATE; TAZAROTENE
4
Combination
Approved
Unknown
TOPICAL
Unknown
Unknown
HALOBETASOL PROPIONATE; TAZAROTENE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-MANNOSE
4
Small molecule
Approved
Unknown
Unknown
Congenital Disorders of Glycosylation; Urinary Tract Infections
Unknown
D-MANNOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
PHA4727WTP
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
3,3',4',5-TETRACHLOROSALICYLANILIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
3,3',4',5-TETRACHLOROSALICYLANILIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
HNE676755I
Molecule Type:
Small molecule
Molecular Formula:
C13H7Cl4NO2
Molecular Weight:
351.02
AlogP:
5.26
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MANNITOL; SORBITOL
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
MANNITOL; SORBITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FELBINAC
4
Small molecule
Approved
Unknown
Unknown
Acute Kidney Injury; Neoplasms; Pain; Thromboembolism; Arthralgia; Myalgia
Unknown
FELBINAC
×
Maximum Phase:
4
First Approval:
None
UNII:
94WNJ5U8L7
Molecule Type:
Small molecule
Molecular Formula:
C14H12O2
Molecular Weight:
212.25
AlogP:
2.98
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
3.0
Source:
POLDINE METHYLSULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POLDINE METHYLSULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
564C0W9848
Molecule Type:
Small molecule
Molecular Formula:
C22H29NO7S
Molecular Weight:
451.54
AlogP:
2.7
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IPRONIAZID
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Monoamine oxidase inhibitor
IPRONIAZID
×
Maximum Phase:
4
First Approval:
None
UNII:
D892HFI3XA
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O
Molecular Weight:
179.22
AlogP:
0.72
PSA:
54.02
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IRON ISOMALTOSIDE 1000
4
Unknown
Approved
Unknown
Unknown
Anemia; Neoplasms; Restless Legs Syndrome; Anemia, Iron-Deficiency; Inflammatory Bowel Diseases; Postpartum Hemorrhage; Renal Insufficiency, Chronic
Supplement
IRON ISOMALTOSIDE 1000
×
Maximum Phase:
4
First Approval:
None
UNII:
3M6325NY1R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEBEVERINE
4
Small molecule
Approved
Unknown
Unknown
Irritable Bowel Syndrome; Digestive System Diseases
Unknown
MEBEVERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
7F80CC3NNV
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5
Molecular Weight:
429.56
AlogP:
4.6
PSA:
57.23
HBD:
0.0
HBA:
#RotB:
13.0
Source:
GLIQUIDONE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus
Unknown
GLIQUIDONE
×
Maximum Phase:
4
First Approval:
None
UNII:
C7C2QDD75P
Molecule Type:
Small molecule
Molecular Formula:
C27H33N3O6S
Molecular Weight:
527.64
AlogP:
3.52
PSA:
121.88
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ENBUCRILATE
4
Small molecule
Approved
Unknown
Unknown
Dermatitis, Atopic; Esophageal and Gastric Varices
Unknown
ENBUCRILATE
×
Maximum Phase:
4
First Approval:
None
UNII:
F8CEP82QNP
Molecule Type:
Small molecule
Molecular Formula:
C8H11NO2
Molecular Weight:
153.18
AlogP:
1.41
PSA:
50.09
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FOLINIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FOLINIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Q573I9DVLP
Molecule Type:
Small molecule
Molecular Formula:
C20H23N7O7
Molecular Weight:
473.45
AlogP:
-0.73
PSA:
219.84
HBD:
7.0
HBA:
#RotB:
10.0
Source:
HYDROCHLOROTHIAZIDE; TELMISARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; TELMISARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRYPTOPHAN
4
Small molecule
Approved
Unknown
Unknown
Breast Neoplasms, Male; Neoplasms; Social Behavior; Cocaine-Related Disorders; Hernias, Diaphragmatic, Congenital; Obesity; Schizophrenia; Emergence Delirium; Depressive Disorder
Unknown
TRYPTOPHAN
×
Maximum Phase:
4
First Approval:
None
UNII:
8DUH1N11BX
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
1.12
PSA:
79.11
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MIZOLASTINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Histamine H1 receptor antagonist
MIZOLASTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
244O1F90NA
Molecule Type:
Small molecule
Molecular Formula:
C24H25FN6O
Molecular Weight:
432.5
AlogP:
3.41
PSA:
70.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN ZINC, EXTENDED
4
Protein
Approved
Unknown
Unknown
Unknown
Insulin receptor agonist
INSULIN ZINC, EXTENDED
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIPYRONE
4
Small molecule
Approved
Unknown
Unknown
Chronic Pain; Gastroenteritis; Migraine Disorders; Sepsis; Fever; Pain
Cyclooxygenase inhibitor
DIPYRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
6429L0L52Y
Molecule Type:
Small molecule
Molecular Formula:
C13H17N3O4S
Molecular Weight:
311.36
AlogP:
0.77
PSA:
84.54
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MET
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MET
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE
4
Combination
Approved
Unknown
OTIC
Unknown
Unknown
CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYETHYL STARCH 130/0.4
4
Oligosaccharide
Approved
Unknown
Unknown
Hypotension; Pulmonary Edema; Coronary Disease; Hip Fractures; Hypovolemia; Sepsis
Unknown
HYDROXYETHYL STARCH 130/0.4
×
Maximum Phase:
4
First Approval:
None
UNII:
1GVO236S58
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NITRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROACTEMRA
4
Antibody
Approved
Unknown
Unknown
Unknown
Unknown
ROACTEMRA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FORMALDEHYDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FORMALDEHYDE
×
Maximum Phase:
4
First Approval:
None
UNII:
1HG84L3525
Molecule Type:
Small molecule
Molecular Formula:
CH2O
Molecular Weight:
30.03
AlogP:
-0.18
PSA:
17.07
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
290
291
292
293
294
295
296
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA